Sapphire Women's Health Group

Sapphire Women's Health Group is a specialized clinical research site located in Wayne, New Jersey, dedicated to conducting Phase II through IV clinical trials in the field of women's health. The organization focuses on a wide range of gynecological conditions, including uterine fibroids, endometriosis, contraception, and menopausal symptoms. In May 2021, Sapphire was acquired by Headlands Research, a global platform of clinical trial sites, to enhance its women's health research capabilities. Led by experienced investigators, the group is recognized for its high-quality data collection and patient recruitment excellence. The facility operates as a high-volume research center, partnering with major pharmaceutical and biotechnology sponsors to advance new therapeutic options.